Trial · NCT00142948
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
NCT00142948, Phase 2, Completed, Baylor College of Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts. Trials, record NCT00142948. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00142948
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
- NCT number
- NCT00142948
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 301 participants, actual
- Lead sponsor
- Baylor College of Medicine
- Conditions
- Heroin Dependence
- Interventions
- Naltrexone, Placebo
- First posted
- 2005-09-02
- Last updated
- 2012-10-24
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Heroin relapse | duration of study | |
| Secondary | HIV risk factors | baseline | |
| Secondary | Psychiatric symptoms (measured at Month 6, and the 3- and 6-month follow-up evaluations) | months 6 and the 3- and 6-month follow-up evaluations | |
| Secondary | Adherence to medication | duration of study | |
| Secondary | Heroin withdrawal symptoms | Month 6, and 3- and 6-month followup |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01DA018863 | Heroin Addiction Treatment: Naltrexone and Lofexidine | KOSTEN, THOMAS RICHARD | BAYLOR COLLEGE OF MEDICINE | NATIONAL INSTITUTE ON DRUG ABUSE | 2004 to 2007 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00142948
GET https://conductscience.org/api/trials/v1/NCT00142948/registered